AT381708B - Verfahren zur herstellung von neuen macroliden und deren pharmazeutisch annehmbaren salzen - Google Patents

Verfahren zur herstellung von neuen macroliden und deren pharmazeutisch annehmbaren salzen

Info

Publication number
AT381708B
AT381708B AT0320783A AT320783A AT381708B AT 381708 B AT381708 B AT 381708B AT 0320783 A AT0320783 A AT 0320783A AT 320783 A AT320783 A AT 320783A AT 381708 B AT381708 B AT 381708B
Authority
AT
Austria
Prior art keywords
pharmaceutically acceptable
acceptable salts
producing new
new macrolides
macrolides
Prior art date
Application number
AT0320783A
Other languages
English (en)
Other versions
ATA320783A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA320783A publication Critical patent/ATA320783A/de
Application granted granted Critical
Publication of AT381708B publication Critical patent/AT381708B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AT0320783A 1982-09-13 1983-09-08 Verfahren zur herstellung von neuen macroliden und deren pharmazeutisch annehmbaren salzen AT381708B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/417,248 US4443436A (en) 1982-09-13 1982-09-13 C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin

Publications (2)

Publication Number Publication Date
ATA320783A ATA320783A (de) 1986-04-15
AT381708B true AT381708B (de) 1986-11-25

Family

ID=23653187

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0320783A AT381708B (de) 1982-09-13 1983-09-08 Verfahren zur herstellung von neuen macroliden und deren pharmazeutisch annehmbaren salzen

Country Status (17)

Country Link
US (1) US4443436A (de)
EP (2) EP0104028B1 (de)
JP (1) JPS5973599A (de)
KR (1) KR850001952B1 (de)
AT (1) AT381708B (de)
AU (1) AU565892B2 (de)
CA (1) CA1229336A (de)
DE (2) DE3381289D1 (de)
DK (1) DK413883A (de)
GB (1) GB2127018B (de)
GR (1) GR78989B (de)
HU (1) HUT35274A (de)
IE (1) IE55917B1 (de)
IL (1) IL69667A0 (de)
NZ (1) NZ205502A (de)
PH (1) PH19760A (de)
ZA (1) ZA836742B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
GB8405087D0 (en) * 1984-02-27 1984-04-04 Omura S Antibiotic
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
US4920103A (en) * 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
US4820694A (en) * 1986-09-29 1989-04-11 Eli Lilly And Company Modifications of 3-O-demethylmycinose in macrocin and lactenocin
EP0262903A3 (de) * 1986-09-29 1988-11-02 Eli Lilly And Company Acylderivate von 20-modifiziertem Tylosin und Desmycosin-Derivate
YU45033B (en) * 1987-04-14 1991-06-30 Pliva Zagreb Process for preparing 10,11,12,13-tetrahydro derivative
ES2099941T3 (es) * 1992-01-14 1997-06-01 Zaidan Hojin Biseibutsu Derivado de 3,4'-didesoxi-micaminosiltilonolido y su produccion.
US5354708A (en) * 1992-06-04 1994-10-11 Taskar Nikhil R Method of nitrogen doping of II-VI semiconductor compounds during epitaxial growth using an amine
TW226373B (de) * 1992-07-15 1994-07-11 Pfizer
AU3121095A (en) * 1994-09-22 1996-04-09 Pfizer Inc. Antibiotic macrolides
PL2999707T3 (pl) * 2013-05-23 2018-09-28 Bayer Animal Health Gmbh Pochodne tylozynowe i sposób ich wytwarzania

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1278441B (de) * 1958-10-29 1968-09-26 Lilly Co Eli Verfahren zur Herstellung von Acylderivaten von Tylosin und Desmycosin und deren Salzen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
US3326759A (en) * 1962-07-19 1967-06-20 Lilly Co Eli Antibiotics macrocin and lactenocin
JPS5321182A (en) * 1976-08-10 1978-02-27 Sanraku Inc Antibiotic angolamycin derivatives and their preparation
GB1587685A (en) * 1977-03-09 1981-04-08 Microbial Chem Res Found Macrolactone derivatives and their production
JPS53130686A (en) * 1977-04-19 1978-11-14 Toyo Jozo Co Ltd 17-deformyl-17-thiazolidyl macrolide antibiotics
JPS53132584A (en) * 1977-04-26 1978-11-18 Toyo Jozo Co Ltd 18-cyano-18-substituted amino-18-deoxy-macrolide anibiotic substance derivative
SE445739B (sv) * 1978-09-14 1986-07-14 Toyo Jozo Kk 3", 4"-diacyltylosinderivat
JPS5655399A (en) * 1979-09-19 1981-05-15 Toyo Jozo Co Ltd Deformyltylosin derivative
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.
JPS5671099A (en) * 1979-11-13 1981-06-13 Toyo Jozo Co Ltd 20-deoxodesmycosin
US4321362A (en) * 1980-06-12 1982-03-23 Eli Lilly And Company De(mycinosyloxy)tylosin and process for its production
US4279896A (en) * 1980-06-23 1981-07-21 Schering Corporation Novel 20-imino macrolide antibacterial agents
US4349665A (en) * 1980-06-27 1982-09-14 Schering Corporation Macrolide antibiotic complex
HU189519B (en) * 1980-07-24 1986-07-28 Eli Lilly And Co,Us Process for preparing 2'''-o-demethyl-macrocin derivatives
US4299953A (en) * 1980-07-29 1981-11-10 Eli Lilly And Company Mycarosyltylactone
US4304856A (en) * 1980-11-10 1981-12-08 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin
US4357325A (en) * 1981-04-20 1982-11-02 Eli Lilly And Company Methods of controlling Pasteurella infections
US4401660A (en) 1981-12-14 1983-08-30 Eli Lilly And Company Ester derivatives of 5-O-mycaminosyl tylonolide and method of using same
JPS58146595A (ja) * 1982-02-25 1983-09-01 Satoshi Omura マクロライド系抗生物質

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1278441B (de) * 1958-10-29 1968-09-26 Lilly Co Eli Verfahren zur Herstellung von Acylderivaten von Tylosin und Desmycosin und deren Salzen

Also Published As

Publication number Publication date
EP0203621A1 (de) 1986-12-03
CA1229336A (en) 1987-11-17
EP0104028A1 (de) 1984-03-28
ZA836742B (en) 1984-04-25
GR78989B (de) 1984-10-02
ATA320783A (de) 1986-04-15
DK413883A (da) 1984-03-14
HUT35274A (en) 1985-06-28
GB2127018B (en) 1986-02-12
DK413883D0 (da) 1983-09-12
IL69667A0 (en) 1983-12-30
KR840005735A (ko) 1984-11-15
AU565892B2 (en) 1987-10-01
EP0104028B1 (de) 1988-08-03
KR850001952B1 (ko) 1985-12-31
GB2127018A (en) 1984-04-04
NZ205502A (en) 1986-03-14
GB8324045D0 (en) 1983-10-12
JPS5973599A (ja) 1984-04-25
IE832132L (en) 1984-03-13
US4443436A (en) 1984-04-17
IE55917B1 (en) 1991-02-27
DE3377576D1 (en) 1988-09-08
DE3381289D1 (de) 1990-04-12
JPH0517240B2 (de) 1993-03-08
AU1871183A (en) 1984-03-22
PH19760A (en) 1986-06-26
EP0203621B1 (de) 1990-03-07

Similar Documents

Publication Publication Date Title
AT385506B (de) Verfahren zur herstellung von neuen carbostyrilderivaten und deren salzen
AT375366B (de) Verfahren zur herstellung von neuen indolderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
AT386198B (de) Verfahren zur herstellung von neuen carbostyrilderivaten und von deren pharmazeutisch annehmbaren salzen
AT381096B (de) Verfahren zur herstellung von neuen cephemverbindungen und deren pharmazeutisch unbedenklichen salzen
ATA908381A (de) Verfahren zur herstellung von neuen carbostyrilverbindungen und deren pharmazeutisch annehmbaren salzen
AT385758B (de) Verfahren zur herstellung von neuen cephemverbindungen und deren salzen
AT381705B (de) Verfahren zur herstellung von neuen thiazolidindion-derivaten und deren salzen
AT381708B (de) Verfahren zur herstellung von neuen macroliden und deren pharmazeutisch annehmbaren salzen
AT383592B (de) Verfahren zur herstellung von neuen carbostyrilderivaten und deren salzen
AT378188B (de) Verfahren zur herstellung von neuen thiazolidinderivaten und deren salzen
AT383127B (de) Verfahren zur herstellung von (5r)-penemderivaten und deren pharmazeutisch annehmbaren salzen
AT381308B (de) Verfahren zur herstellung von neuen fluorprostacyclinen und von deren salzen
AT379804B (de) Verfahren zur herstellung von neuen phenaethylimidazolderivaten und von deren salzen
AT384810B (de) Verfahren zur herstellung von psoralenfreien neuen 6-alkylangelicinen und von deren salzen
AT353960B (de) Verfahren zur herstellung von neuen bis-peni- cillanoyloxy-alkanen und deren pharmazeutisch annehmbaren salzen
ATA238481A (de) Verfahren zur herstellung von neuen acylaminophenylpyridinderivaten und deren salzen
ATA238683A (de) Verfahren zur herstellung von neuen eburnan-oxim-aether-derivaten und von deren saeureadditionssalzen
ATA154183A (de) Verfahren zur herstellung von neuen imidazochinoxalinen und von deren salzen
ATA238583A (de) Verfahren zur herstellung von neuen eburnanderivaten und deren saeureadditionssalzen
AT366665B (de) Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen
ATA315781A (de) Verfahren zur herstellung von neuen pyridinylaminophenolen und deren salzen
AT384806B (de) Verfahren zur herstellung von neuen 4-aryl-2-methyl-1,2,3,4-tetrahydro-isochinolinderivaten und deren salzen
AT376438B (de) Verfahren zur herstellung von neuen indolizinderivaten und von deren pharmazeutisch zulaessigen saeureadditionssalzen
AT381099B (de) Verfahren zur herstellung von neuen tetrapeptiden und deren pharmazeutisch annehmbaren salzen
ATA467182A (de) Verfahren zur herstellung von neuen 1,3-benzodioxol-derivaten und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee